In contrast, TNFR2 ablation in monocytes/macrophages resulted in impaired peripheral immunity and alleviated neuropathology and EAE motor disease development (Gao et al., 2017). The gene discussed is TNFRSF1B; the disease is glycogen storage disease VI.